2006
DOI: 10.1097/01.ccm.0000198108.38349.28
|View full text |Cite
|
Sign up to set email alerts
|

Graft protein C entrapment is associated with reduced phagocyte activation during reperfusion in human liver transplantation

Abstract: Protein C entrapment occurs immediately during reperfusion in the graft without concomitant activated protein C release, suggesting a shortage of activated protein C in the reperfused graft. The ongoing inflammatory response during reperfusion may lead to protein C and activated protein C utilization within the graft. Indeed, hepatic protein C entrapment is associated with reduced hepatic phagocyte activation, suggesting a regulatory role for protein C pathway in hepatic reperfusion in human liver transplantat… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
7
0

Year Published

2007
2007
2015
2015

Publication Types

Select...
6

Relationship

3
3

Authors

Journals

citations
Cited by 9 publications
(8 citation statements)
references
References 50 publications
1
7
0
Order By: Relevance
“…Although we could not obtain blood samples across the hepatic circulation postoper- atively to investigate hepatic HMGB1 release, HMGB1 levels in systemic circulation declined rapidly after reperfusion, and postoperatively, HMGB1 was undetectable in most patients. This suggests that, despite inducing intense momentary hepatic phagocyte activation and sequestration, 33,35 reperfusion does not lead to extensive delayed hepatic HMGB1 release into systemic circulation.…”
Section: Discussionmentioning
confidence: 95%
“…Although we could not obtain blood samples across the hepatic circulation postoper- atively to investigate hepatic HMGB1 release, HMGB1 levels in systemic circulation declined rapidly after reperfusion, and postoperatively, HMGB1 was undetectable in most patients. This suggests that, despite inducing intense momentary hepatic phagocyte activation and sequestration, 33,35 reperfusion does not lead to extensive delayed hepatic HMGB1 release into systemic circulation.…”
Section: Discussionmentioning
confidence: 95%
“…EPCR-GPI cell painting would be well suited for ex vivo cell therapies aimed at improving survival and engraftment of transplants. Both APC and liposomal thrombomodulin improved the outcome of pancreatic islets transplantation for type I diabetes (50)(51)(52)(53), and APC's cytoprotective effects have been shown to reduce graft-related injury (54,55). Furthermore, overexpression of EPCR on murine transplant tissue protected against transplantation-related thrombotic and inflammatory injury (56).…”
Section: Discussionmentioning
confidence: 99%
“…Although we could not obtain blood samples across the hepatic circulation postoperatively to investigate hepatic HMGB1 release, HMGB1 levels in systemic circulation declined rapidly after reperfusion, and postoperatively, HMGB1 was undetectable in most patients. This suggests that, despite inducing intense momentary hepatic phagocyte activation and sequestration,33, 35 reperfusion does not lead to extensive delayed hepatic HMGB1 release into systemic circulation.…”
Section: Discussionmentioning
confidence: 95%